Journal
PHARMACOLOGICAL REPORTS
Volume 69, Issue 5, Pages 1021-1029Publisher
POLISH ACAD SCIENCES INST PHARMACOLOGY
DOI: 10.1016/j.pharep.2017.03.020
Keywords
Naringenin; Complete Freund's adjuvant; NF-kappa B; Nrf-2/HO-1 pathway
Categories
Funding
- Department of Urology, Department of Orthopaedics, the Second People's Hospital of Liaocheng, China
Ask authors/readers for more resources
Background: Naringenin, a bioflavonoid present in various species of citrus fruit, tomatoes and grapes, has been shown to have various pharmacological effects. We evaluated the anti-arthritic potential of naringenin in formaldehyde-induced inflammation and complete Freund's adjuvant (CFA)-induced arthritis. Methods: For both evaluations, rats were divided into groups of six. Different doses of naringenin (5, 10 and 20 mg/kg) were used in the models. Body weight and the arthritic index were assessed. Biochemical and antioxidant parameters were determined. Naringenin dose-dependently reduced joint inflammation, decreasing the joint diameter and inflammatory cell infiltration. Results: Naringenin-treated rats showed an improvement in the synovium redox status (down-regulation of malondialdehyde and glutathione and up-regulation of Catalase (CAT) and superoxide dismutase levels). Naringenin significantly reduced the level of the inflammatory marker TNF-alpha. Naringenin increased Nrf-2/HO-1 and reduced NF-kappa B mRNA levels in CFA-treated animal joints. Additionally, naringenin treatment decreased the expression of extracellular matrix degrading enzymes, such as matrix metalloproteinase (MMP-3 and MMP-9), in CFA-induced arthritic rats. Conclusions: We conclude that naringenin exerts anti-arthritic effects by downregulating NF-kappa B and activating the Nrf-2/HO-1 pathway. (c) 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available